TGF-β in infections and infectious diseases

Microbes and Infection

Volumn 1, Issue 15, 1999, Pages 1313-1325

  Reed, Steven G ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

Immunoregulation; Infection models; TGF

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ARTICLE; CYTOKINE PRODUCTION; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RESISTANCE; LEISHMANIASIS; MACROPHAGE ACTIVATION; MOUSE; MYCOBACTERIOSIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRYPANOSOMIASIS;

ANIMALIA; CORYNEBACTERINEAE; HUMAN IMMUNODEFICIENCY VIRUS; PROTOZOA; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0033401855     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(99)00252-X     Document Type: Review

References (74)

1. Ghalib H.W., Piuvezam M.R., Skeiky Y.A., Siddig M., Hashim F.A., El-Hassan A.M., Russo D.M., Reed S.G. Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J. Clin. Invest. 92:1993;324-329.
2. Reed S.G., Larson C.L., Speer C.A. Contact sensitivity responses in mice infected with Trypanosoma cruzi. Infect. Immun. 22:1978;548-554.
3. Reed S.G., Roters S.B., Goidl E.A. Spleen cell-mediated suppression of IgG production to a non-parasite antigen during chronic Trypanosoma cruzi infection in mice. J. Immunol. 131:1983;1978-1982.
4. Reed S.G., Inverso J.A., Roters S.B. Suppressed antibody responses to sheep erythrocytes in mice with chronic Trypanosoma cruzi infections are restored with interleukin 2. J. Immunol. 133:1984;3333-3337.
5. Reed S.G., Pihl D.L., Grabstein K.H. Immune deficiency in chronic Trypanosoma cruzi infection, Recombinant IL-1 restores Th function for antibody production. J. Immunol. 142:1989;2067-2071.
6. Reed S.G., Grabstein K.H., Pihl D.L., Morrissey P.J. Recombinant granulocyte-macrophage colony-stimulating factor restores deficient immune responses in mice with chronic Trypanosoma cruzi infections. J. Immunol. 145:1990;1564-1570.
7. Tsunawaki S., Sporn M., Ding A., Nathan C. Deactivation of macrophages by transforming growth factor-beta. Nature. 334:1988;260-262.
8. Ding A., Nathan C.F., Graycar J., Derynck R., Stuehr D.J., Srimal S. Macrophage deactivating factor and transforming growth factors-beta 1 -beta 2 and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma. J. Immunol. 145:1990;940-944.
9. Silva J.S., Twardzik D.R., Reed S.G. Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-β). J. Exp. M. 174:1991;539-545.
10. Reed S.G. In vivo administration of recombinant IFN-gamma induces macrophage activation and prevents acute disease immune suppression and death in experimental Trypanosoma cruzi infections. J. Immunol. 140:1988;4342-4347.
11. Reed S.G., Nathan C.F., Pihl D.L., Rodricks P., Shanebeck K., Conlon P.J., Grabstein K.H. Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide, Comparison with interferon gamma. J. Exp. M. 166:1987;1734-1746.
12. Hansen D.S., Villacres-Eriksson M., Akerblom L., Hellman U., Segura E., Carlomagno M., Morein B. An immunoaffinity-purified Trypanosoma cruzi antigen suppresses cellular proliferation through a TGF-β-mediated mechanism. Scand. J. Immunol. 47:1998;509-516.
13. Ming M., Ewen M.E., Pereira M.E. Trypanosome invasion of mammalian cells requires activation of the TGF beta signaling pathway. Cell. 82:1995;287-296.
14. Nelson B.J., Ralph P., Green S.J., Nacy C.A. Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-beta 1. J. Immunol. 146:1991;1849-1857.
15. Nelson B.J., Danielpour D., Rossio J.L., Turpin J., Nacy C.A. Interleukin-2 suppresses activated macrophage intracellular killing activity by inducing macrophages to secrete TGF-beta. J. Leukoc. Biol. 55:1994;81-90.
16. Barral-Netto M., Barral A., Brownell C.E., Skeiky Y.A., Ellingsworth L.R., Twardzik D.R., Reed S.G. Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism. Science. 257:1992;545-548.
17. Li J., Hunter C.A., Farrell J.P. Anti-TGF-beta treatment promotes rapid healing of Leishmania major infection in mice by enhancing in vivo nitric oxide production. J. Immunol. 162:1999;974-979.
18. Stenger S., Thuring H., Rollinghoff M., Bogdan C. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. M. 180:1994;783-793.
19. Wilson M.E., Young B.M., Davidson B.L., Mente K.A., McGowan S.E. The importance of TGF-beta in murine visceral leishmaniasis. J. Immunol. 161:1998;6148-6155.
20. Rodrigues V.J., Santana D.S., Campos-Neto A. Transforming growth factor beta and immunosuppression in experimental visceral leishmaniasis. Infect. Immun. 66:1998;1233-1236.
21. Carvalho E.M., Badaro R., Reed S.G., Jones T.C., Johnson W.D.J. Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. J. Clin. Invest. 76:1985;2066-2069.
22. Carvalho E.M., Bacellar O., Brownell C., Regis T., Coffman R.L., Reed S.G. Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis. J. Immunol. 152:1994;5949-5956.
23. Barral A., Barral-Netto M., Yong E.C., Brownell C.E., Twardzik D.R., Reed S.G. Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis. Proc. Natl. Acad. Sci. USA. 90:1993;3442-3446.
24. Walton B.C. American cutaneous and mucocutaneous leishmaniasis. Peters W, Killick-Kendrick R. The Leishmaniases in Biology and Medicine: Vol. II - Clinical Aspects and Control. 1987;637-664 Academic Press, London.
25. Barral A., Teixeira M., Reis P., Vinhas V., Costa J., Lessa H., Bittencourt A.L., Reed S., Carvalho E.M., Barral-Netto M. Transforming growth factor-beta in human cutaneous leishmaniasis. Am. J. Pathol. 147:1995;947-954.
26. Melby P.C., Andrade-Narvaez F.J., Darnell B.J., Valencia-Pacheco G., Tryon V.V., Palomo-Cetina A. Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis. Infect. Immun. 62:1994;837-842.
27. Soares M.B., David J.R., Titus R.G. An in vitro model for infection with Leishmania major that mimics the immune response in mice. Infect. Immun. 65:1997;2837-2845.
28. Bermudez L.E. Production of transforming growth factor-beta by Mycobacterium avium-infected human macrophages is associated with unresponsiveness to IFN-gamma. J. Immunol. 150:1993;1838-1845.
29. Hunter C.A., Bermudez L., Beernink H., Waegell W., Remington J.S. Transforming growth factor-beta inhibits interleukin-12-induced production of interferon-gamma by natural killer cells: a role for transforming growth factor-beta in the regulation of T cell-independent resistance to Toxoplasma gondii. Eur. J. Immunol. 25:1995;994-1000.
30. Chao C.C., Hu S., Gekker G., Novick W.J.J., Remington J.S., Peterson P.K. Effects of cytokines on multiplication of Toxoplasma gondii in microglial cells. J. Immunol. 150:1993;3404-3410.
31. Omer F.M., Riley E.M. Transforming growth factor beta production is inversely correlated with severity of murine malaria infection. J. Exp. M. 188:1998;39-48.
32. Toossi Z., Gogate P., Shiratsuchi H., Young T., Ellner J.J. Enhanced production of TGF-beta by blood monocytes from patients with active tuberculosis and presence of TGF-beta in tuberculous granulomatous lung lesions. J. Immunol. 154:1995;465-473.
33. Hirsch C.S., Yoneda T., Averill L., Ellner J.J., Toossi Z. Enhancement of intracellular growth of Mycobacterium tuberculosis in human monocytes by transforming growth factor-beta 1. J. Infect. Dis. 170:1994;1229-1237.
34. Toossi Z., Young T.G., Averill L.E., Hamilton B.D., Shiratsuchi H., Ellner J.J. Induction of transforming growth factor beta 1 by purified protein derivative of Mycobacterium tuberculosis. Infect. Immun. 63:1995;224-228.
35. Hirsch C.S., Hussain R., Toossi Z., Dawood G., Shahid F., Ellner J.J. Cross-modulation by transforming growth factor beta in human tuberculosis: suppression of antigen-driven blastogenesis and interferon gamma production. Proc. Natl. Acad. Sci. USA. 93:1996;3193-3198.
36. Hirsch C.S., Ellner J.J., Blinkhorn R., Toossi Z. In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta. Proc. Natl. Acad. Sci. USA. 94:1997;3926-3931.
37. Dahl K.E., Shiratsuchi H., Hamilton B.D., Ellner J.J., Toossi Z. Selective induction of transforming growth factor beta in human monocytes by lipoarabinomannan of Mycobacterium tuberculosis. Infect. Immun. 64:1996;399-405.
38. Dai G., McMurray D.N. Altered cytokine production and impaired antimycobacterial immunity in protein-malnourished guinea pigs. Infect. Immun. 66:1998;3562-3568.
39. Bermudez L.E., Covaro G., Remington J. Infection of murine macrophages with Toxoplasma gondii is associated with release of transforming growth factor beta and downregulation of expression of tumor necrosis factor receptors. Infect. Immun. 61:1993;4126-4130.
40. Champsi J., Young L.S., Bermudez L.E. Production of TNF-alpha IL-6 and TGF-beta and expression of receptors for TNF-alpha and IL-6 during murine Mycobacterium avium infection. Immunology. 84:1995;549-554.
41. Bermudez L.E., Wu M., Young L.S. Interleukin-12-stimulated natural killer cells can activate human macrophages to inhibit growth of Mycobacterium avium. Infect. Immun. 63:1995;4099-4104.
42. Hsu N., Young L.S., Bermudez L.E. Response to stimulation with recombinant cytokines and synthesis of cytokines by murine intestinal macrophages infected with the Mycobacterium avium complex. Infect. Immun. 63:1995;528-533.
43. Denis M., Ghadirian E. Transforming growth factor beta (TGF-β 1) plays a detrimental role in the progression of experimental Mycobacterium avium infection; in vivo and in vitro evidence. Microb. Pathog. 11:1991;367-372.
44. Rodel J., Straube E., Lungershausen W., Hartmann M., Groh A. Secretion of cytokines by human synoviocytes during in vitro infection with Chlamydia trachomatis. J. Rheumatol. 25:1998;2161-2168.
45. Rasmussen S.J., Eckmann L., Quayle A.J., Shen L., Zhang Y.X., Anderson D.J., Fierer J., Stephens R.S., Kagnoff M.F. Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J. Clin. Invest. 99:1997;77-87.
46. Williams D.M., Grubbs B.G., Park-Snyder S., Rank R.G., Bonewald L.F. Activation of latent transforming growth factor beta during Chlamydia trachomatis-induced murine pneumonia. Res. Microbiol. 147:1996;251-262.
47. Michelson S., Alcami J., Kim S.J., Danielpour D., Bachelerie F., Picard L., Bessia C., Paya C., Virelizier J.L. Human cytomegalovirus infection induces transcription and secretion of transforming growth factor beta 1. J. Virol. 68:1994;5730-5737.
48. Haagmans B.L., Teerds K.J., Van Den Eijnden-Van Raai J.A.J., Horzine K.M.C., Schijns V.E. Transforming growth factor beta production during rat cytomegalovirus infection. J. Gen. Virol. 78:(Pt 1):1997;205-213.
49. Yoo Y.D., Ueda H., Park K., Flanders K.C., Lee Y.I., Jay G., Kim S.J. Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator, Role in HBV pathogenesis. J. Clin. Invest. 97:1996;388-395.
50. Paradis V., Mathurin P., Laurent A., Charlotte F., Vidaud M., Poynard T., Hoang C., Opolon P., Bedossa P. Histological features predictive of liver fibrosis in chronic hepatitis C infection. J. Clin. Pathol. 49:1996;998-1004.
51. Nelson D.R., Gonzalez-Peralta R.P., Qian K., Xu Y., Marousis C.G., Davis G.L., Lau J.Y. Transforming growth factor-beta 1 in chronic hepatitis C. J.Viral. Hepat. 4:1997;29-35.
52. Kanto T., Takehara T., Katayama K., Ito A., Mochizuki K., Kuzushita N., Tatsumi T., Sasaki Y., Kasahara A., Hayashi N., Hori M. Neutralization of transforming growth factor beta 1 augments hepatitis C virus-specific cytotoxic T lymphocyte induction in vitro. J. Clin. Immunol. 17:1997;462-471.
53. Uhl E.W., Castleman W.L., Sorkness R.L., Busse W.W., Lemanske R.F.J., McAllister P.K. Parainfluenza virus-induced persistence of airway inflammation fibrosis and dysfunction associated with TGF-beta 1 expression in brown Norway rats. Am. J. Respir. Crit. Care. M. 154:1996;1834-1842.
54. Schultz-Cherry S., Hinshaw V.S. Influenza virus neuraminidase activates latent transforming growth factor beta. J. Virol. 70:1996;8624-8629.
55. Kekow J., Wachsman W., McCutchan J.A., Cronin M., Carson D.A., Lotz M. Transforming growth factor beta and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection. Proc. Natl. Acad. Sci. USA. 87:1990;8321-8325.
56. Lotz M., Seth P. TGF beta and HIV infection. Ann. NY Acad. Sci. 685:1993;501-511.
57. Valdez H., Lederman M.M. Cytokines and cytokine therapies in HIV infection. AIDS Clin. Rev. 1997;187-228.
58. Kekow J., Wachsman W., McCutchan J.A., Gross W.L., Zachariah M., Carson D.A., Lotz M. Transforming growth factor-beta and suppression of humoral immune responses in HIV infection. J. Clin. Invest. 87:1991;1010-1016.
59. Navikas V., Link J., Wahren B., Persson C., Link H. Increased levels of interferon-gamma (IFN-gamma) IL-4 and transforming growth factor-beta (TGF-beta) mRNA expressing blood mononuclear cells in human HIV infection. Clin. Exp. Immunol. 96:1994;59-63.
60. Lazdins J.K., Klimkait T., Alteri E., Walker M., Woods-Cook K., Cox D., Bilbe G., Shipman R., Cerletti N., McMaster G. TGF-beta: upregulator of HIV replication in macrophages. Res. Virol. 142:1991;239-242.
61. Lazdins J.K., Klimkait T., Woods-Cook K., Walker M., Alteri E., Cox D., Cerletti N., Shipman R., Bilbe G., McMaster G. In vitro effect of transforming growth factor-beta on progression of HIV-1 infection in primary mononuclear phagocytes. J. Immunol. 147:1991;1201-1207.
62. Lazdins J.K., Klimkait T., Woods-Cook K., Walker M., Alteri E., Cox D., Cerletti N., Shipman R., Bilbe G., McMaster G. The replicative restriction of lymphocytotropic isolates of HIV-1 in macrophages is overcome by TGF-beta. AIDS. Res. Hum. Retroviruses. 8:1992;505-511.
63. Gibellini D., Zauli G., Re M.C., Milani D., Furlini G., Caramelli E., Capitani S., LaPlaca M. Recombinant human immunodeficiency virus type-1 (HIV-1) Tat protein sequentially up-regulates IL-6 and TGF-beta 1 mRNA expression and protein synthesis in peripheral blood monocytes. Br. J. Haematol. 88:1994;261-267.
64. Hu R., Oyaizu N., Than S., Kalyanaraman V.S., Wang X.P., Pahwa S. HIV-1 gp160 induces transforming growth factor-beta production in human PBMC. Clin. Immunol. Immunopathol. 80:1996;283-289.
65. McKiel V., Gu Z., Wainberg M.A., Hiscott J. Inhibition of human immunodeficiency virus type 1 multiplication by transforming growth factor beta 1 and AZT in HIV-1-infected myeloid cells. J. Interf. Cytokine Res. 15:1995;849-855.
66. Silva J.S., Morrissey P.J., Grabstein K.H., Mohler K.M., Anderson D., Reed S.G. Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection. J. Exp. M. 175:1992;169-174.
67. Reed S.G., Brownell C.E., Russo D.M., Silva J.S., Grabstein K.H., Morrissey P.J. IL-10 mediates susceptibility to Trypanosoma cruzi infection. J. Immunol. 153:1994;3135-3140.
68. Akridge R.E., Oyafuso L.K., Reed S.G. IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J. Immunol. 153:1994;5782-5789.
69. Thompson T.C., Kadmon D., Timme T.L., Merz V.W., Egawa S., Krebs T., Scardino P.T., Park S.H. Experimental oncogene induced prostate cancer. Cancer Surv. 11:1991;55-71.
70. Hollsberg P., Ausubel L.J., Hafler D.A. Human T cell lymphotropic virus type I-induced T cell activation, Resistance to TGF-beta 1-induced suppression. J. Immunol. 153:1994;566-573.
71. Spaccapelo R., Romani L., Tonnetti L., Cenci E., Mencacci A., DelSero G., Tognellini R., Reed S.G., Puccetti P., Bistoni F. TGF-beta is important in determining the in vivo patterns of susceptibility or resistance in mice infected with Candida albicans. J. Immunol. 155:1995;1349-1360.
72. Chen W., Jin W., Cook M., Weiner H.L., Wahl S.M. Oral delivery of group A streptococcal cell walls augments circulating TGF-beta and suppresses streptococcal cell wall arthritis. J. Immunol. 161:1998;6297-6304.
73. Song X.Y., Gu M., Jin W.W., Klinman D.M., Wahl S.M. Plasmid DNA encoding transforming growth factor-beta1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model. J. Clin. Invest. 101:1998;2615-2621.
74. Mc Cartney-Francis N.L., Frazier-Jessen M., Wahl S.M. TGF-beta: a balancing act. Int. Rev. Immunol. 16:1998;553-580.